Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy

R. Hill, M. Rabb, P. A. Madureira, D. Clements, S. A. Gujar, D. M. Waisman, C. A. Giacomantonio, P. W. K. Lee

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science